2023-12-012024-11-302024-11-30false13745711PATEL EYECARE LIMITED2025-05-2986220falseiso4217:GBPxbrli:pure137457112023-11-30137457112024-11-30137457112023-12-012024-11-30137457112022-11-30137457112023-11-30137457112022-12-012023-11-3013745711bus:SmallEntities2023-12-012024-11-3013745711bus:AuditExempt-NoAccountantsReport2023-12-012024-11-3013745711bus:FullAccounts2023-12-012024-11-3013745711bus:PrivateLimitedCompanyLtd2023-12-012024-11-3013745711core:WithinOneYear2024-11-3013745711core:AfterOneYear2024-11-3013745711core:WithinOneYear2023-11-3013745711core:AfterOneYear2023-11-3013745711core:ShareCapital2024-11-3013745711core:SharePremium2024-11-3013745711core:RevaluationReserve2024-11-3013745711core:OtherReservesSubtotal2024-11-3013745711core:RetainedEarningsAccumulatedLosses2024-11-3013745711core:ShareCapital2023-11-3013745711core:SharePremium2023-11-3013745711core:RevaluationReserve2023-11-3013745711core:OtherReservesSubtotal2023-11-3013745711core:RetainedEarningsAccumulatedLosses2023-11-3013745711core:LandBuildings2024-11-3013745711core:PlantMachinery2024-11-3013745711core:Vehicles2024-11-3013745711core:FurnitureFittings2024-11-3013745711core:OfficeEquipment2024-11-3013745711core:NetGoodwill2024-11-3013745711core:IntangibleAssetsOtherThanGoodwill2024-11-3013745711core:ListedExchangeTraded2024-11-3013745711core:UnlistedNon-exchangeTraded2024-11-3013745711core:LandBuildings2023-11-3013745711core:PlantMachinery2023-11-3013745711core:Vehicles2023-11-3013745711core:FurnitureFittings2023-11-3013745711core:OfficeEquipment2023-11-3013745711core:NetGoodwill2023-11-3013745711core:IntangibleAssetsOtherThanGoodwill2023-11-3013745711core:ListedExchangeTraded2023-11-3013745711core:UnlistedNon-exchangeTraded2023-11-3013745711core:LandBuildings2023-12-012024-11-3013745711core:PlantMachinery2023-12-012024-11-3013745711core:Vehicles2023-12-012024-11-3013745711core:FurnitureFittings2023-12-012024-11-3013745711core:OfficeEquipment2023-12-012024-11-3013745711core:NetGoodwill2023-12-012024-11-3013745711core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3013745711core:ListedExchangeTraded2023-12-012024-11-3013745711core:UnlistedNon-exchangeTraded2023-12-012024-11-3013745711core:MoreThanFiveYears2023-12-012024-11-3013745711core:Non-currentFinancialInstruments2024-11-3013745711core:Non-currentFinancialInstruments2023-11-3013745711dpl:CostSales2023-12-012024-11-3013745711dpl:DistributionCosts2023-12-012024-11-3013745711core:LandBuildings2023-12-012024-11-3013745711core:PlantMachinery2023-12-012024-11-3013745711core:Vehicles2023-12-012024-11-3013745711core:FurnitureFittings2023-12-012024-11-3013745711core:OfficeEquipment2023-12-012024-11-3013745711dpl:AdministrativeExpenses2023-12-012024-11-3013745711core:NetGoodwill2023-12-012024-11-3013745711core:IntangibleAssetsOtherThanGoodwill2023-12-012024-11-3013745711dpl:GroupUndertakings2023-12-012024-11-3013745711dpl:ParticipatingInterests2023-12-012024-11-3013745711dpl:GroupUndertakingscore:ListedExchangeTraded2023-12-012024-11-3013745711core:ListedExchangeTraded2023-12-012024-11-3013745711dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-12-012024-11-3013745711core:UnlistedNon-exchangeTraded2023-12-012024-11-3013745711dpl:CostSales2022-12-012023-11-3013745711dpl:DistributionCosts2022-12-012023-11-3013745711core:LandBuildings2022-12-012023-11-3013745711core:PlantMachinery2022-12-012023-11-3013745711core:Vehicles2022-12-012023-11-3013745711core:FurnitureFittings2022-12-012023-11-3013745711core:OfficeEquipment2022-12-012023-11-3013745711dpl:AdministrativeExpenses2022-12-012023-11-3013745711core:NetGoodwill2022-12-012023-11-3013745711core:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3013745711dpl:GroupUndertakings2022-12-012023-11-3013745711dpl:ParticipatingInterests2022-12-012023-11-3013745711dpl:GroupUndertakingscore:ListedExchangeTraded2022-12-012023-11-3013745711core:ListedExchangeTraded2022-12-012023-11-3013745711dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-12-012023-11-3013745711core:UnlistedNon-exchangeTraded2022-12-012023-11-3013745711core:NetGoodwill2024-11-3013745711core:IntangibleAssetsOtherThanGoodwill2024-11-3013745711core:LandBuildings2024-11-3013745711core:PlantMachinery2024-11-3013745711core:Vehicles2024-11-3013745711core:FurnitureFittings2024-11-3013745711core:OfficeEquipment2024-11-3013745711core:AfterOneYear2024-11-3013745711core:WithinOneYear2024-11-3013745711core:ListedExchangeTraded2024-11-3013745711core:UnlistedNon-exchangeTraded2024-11-3013745711core:ShareCapital2024-11-3013745711core:SharePremium2024-11-3013745711core:RevaluationReserve2024-11-3013745711core:OtherReservesSubtotal2024-11-3013745711core:RetainedEarningsAccumulatedLosses2024-11-3013745711core:NetGoodwill2023-11-3013745711core:IntangibleAssetsOtherThanGoodwill2023-11-3013745711core:LandBuildings2023-11-3013745711core:PlantMachinery2023-11-3013745711core:Vehicles2023-11-3013745711core:FurnitureFittings2023-11-3013745711core:OfficeEquipment2023-11-3013745711core:AfterOneYear2023-11-3013745711core:WithinOneYear2023-11-3013745711core:ListedExchangeTraded2023-11-3013745711core:UnlistedNon-exchangeTraded2023-11-3013745711core:ShareCapital2023-11-3013745711core:SharePremium2023-11-3013745711core:RevaluationReserve2023-11-3013745711core:OtherReservesSubtotal2023-11-3013745711core:RetainedEarningsAccumulatedLosses2023-11-3013745711core:NetGoodwill2022-11-3013745711core:IntangibleAssetsOtherThanGoodwill2022-11-3013745711core:LandBuildings2022-11-3013745711core:PlantMachinery2022-11-3013745711core:Vehicles2022-11-3013745711core:FurnitureFittings2022-11-3013745711core:OfficeEquipment2022-11-3013745711core:AfterOneYear2022-11-3013745711core:WithinOneYear2022-11-3013745711core:ListedExchangeTraded2022-11-3013745711core:UnlistedNon-exchangeTraded2022-11-3013745711core:ShareCapital2022-11-3013745711core:SharePremium2022-11-3013745711core:RevaluationReserve2022-11-3013745711core:OtherReservesSubtotal2022-11-3013745711core:RetainedEarningsAccumulatedLosses2022-11-3013745711core:AfterOneYear2023-12-012024-11-3013745711core:WithinOneYear2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:CostValuation2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-012024-11-3013745711core:Non-currentFinancialInstrumentscore:CostValuation2024-11-3013745711core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-3013745711core:Non-currentFinancialInstrumentscore:CostValuation2023-11-3013745711core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-3013745711core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-3013745711bus:Director12023-12-012024-11-3013745711bus:Director22023-12-012024-11-30

PATEL EYECARE LIMITED

Registered Number
13745711
(England and Wales)

Unaudited Financial Statements for the Year ended
30 November 2024

PATEL EYECARE LIMITED
Company Information
for the year from 1 December 2023 to 30 November 2024

Directors

PATEL, Karen Elizabeth Karnesh
PATEL, Karnesh Chandrakant, Dr

Registered Address

71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Registered Number

13745711 (England and Wales)
PATEL EYECARE LIMITED
Statement of Financial Position
30 November 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets3170170
170170
Current assets
Cash at bank and on hand13,04614,245
13,04614,245
Creditors amounts falling due within one year4(3,749)(2,125)
Net current assets (liabilities)9,29712,120
Total assets less current liabilities9,46712,290
Net assets9,46712,290
Capital and reserves
Called up share capital22
Profit and loss account9,46512,288
Shareholders' funds9,46712,290
The financial statements were approved and authorised for issue by the Board of Directors on 29 May 2025, and are signed on its behalf by:
PATEL, Karnesh Chandrakant, Dr
Director
Registered Company No. 13745711
PATEL EYECARE LIMITED
Notes to the Financial Statements
for the year ended 30 November 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Going concern
The company continues to adopt the going concern basis in preparing its financial statements.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are measured at cost less accumulated amortisation and any accumulated impairment losses.
2.Average number of employees

20242023
Average number of employees during the year00
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 December 23170170
At 30 November 24170170
Net book value
At 30 November 24170170
At 30 November 23170170
4.Creditors: amounts due within one year

2024

2023

££
Other creditors3,2871,663
Accrued liabilities and deferred income462462
Total3,7492,125
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.